Enterovirus 71 (EV71), a major cause of hand, foot, and mouth disease and herpangina in young children, can be controlled by a vaccine, concluded 2 randomized, placebo-controlled phase 3 trials conducted in China. The EV71 genotype C4 has caused thousands of deaths in China and large outbreaks in the Asia-Pacific region.
One trial randomly assigned 12 000 healthy children aged 6 to 71 months to receive 2 injections of inactivated EV71 vaccine or placebo with a 4-week interval between doses (Li R et al. N Engl J Med. 2014;370:829-837). In children who received 2 doses, the vaccine was 97.4% protective against hand, foot, and mouth disease over 11 months and 2 epidemic periods. Most adverse events were mild and were more common in the vaccine group.
Slomski A. Vaccines for Enterovirus 71. JAMA. 2014;311(16):1602. doi:10.1001/jama.2014.3911
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: